SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (27861)2/5/1999 2:48:00 PM
From: Henry Niman  Respond to of 32384
 
Walter, Two approvals in a week will get some attention. LGND's pipeline is considered by many to be the best in the industry, and they haven't had much coverage on the news yet. As the industry begins to seriously consolidate, the survivors will do well, and LGND is clearly one of the survivors. Still haven't seen the press release yet, but LGND's sales force should be pretty active.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News